Parabilis Medicines' corporate headquarters is located at 30 Acorn Park Drive, Cambridge, MA 02140.
Parabilis Medicines was founded in 2015.
Parabilis Medicines announced its new Company name on October 28, 2024.
Parabilis Medicines is incorporated in Delaware.
Parabilis Medicines completed its IPO on June 10, 2026.
Parabilis Medicines is listed on The Nasdaq Select Market under ticker symbol PBLS.
Parablis Medicines' fiscal year end is December 31 of each year.
Our SEC Filings can be found on www.sec.gov and are also available under the “SEC Filings” section of the “Investors” page located at our website.
Visit the Email Alerts section of Parabilis Medicines' Investor Relations website.
Parabilis Medicines does not currently have a direct stock purchase plan for investors. Our stock may be purchased through a licensed securities broker.
The transfer agent and registrar for the common stock of Parabilis Medicines’ stock is:
Computershare Trust Company, N.A.
250 Royall Street
Canton, MA 02021
(800) 962-4284
To change the address on your shareholder account you must send both your old and new addresses to our transfer agent, Computershare Trust Company, N.A., 250 Royall Street, Canton, Massachusetts 02021.
To transfer stock or replace a lost stock certificate, contact our transfer agent, Computershare Trust Company, N.A.
The auditor for Parabilis Medicines is PricewaterhouseCoopers LLP.
Legal counsel for Parabilis Medicines is Goodwin Procter LLP.
For additional questions, contact: Carlo Tanzi, Ph.D., Kendall Investor Relations, ctanzi@kendallir.com.